AcuCort CEO discusses rights issue, US expansion, Zeqmelit NDA
AcuCort CEO Jonas Jönmark discussed the company's rights issue, use of proceeds, preparations for a planned US NDA for Zeqmelit, and US launch planning in an interview on Oct. 6. Management also addressed the FDA process and international expansion strategy.